ASH2L
Summary:
Loading, please wait...
Name | OMIM ID | Ensembl ID | HGNC ID | PHARMGKB ID | Map Location |
---|---|---|---|---|---|
OMIM IDMIM:604782 Ensembl IDEnsembl:ENSG00000129691 HGNC IDHGNC:HGNC:744 PHARMGKB IDPA25044 Map Location8p11.23 |
GO terms in ASH2L
Loading, please wait...
Term Type | Evidence Type | GO Term ID | GO Des. |
---|---|---|---|
MF | IPI | GO:0005515 | protein binding |
MF | IDA | GO:0008013 | beta-catenin binding |
MF | TAS | GO:0018024 | histone-lysine N-methyltransferase activity |
MF | IBA | GO:0042800 | histone methyltransferase activity (H3-K4 specific) |
MF | IDA | GO:0042800 | histone methyltransferase activity (H3-K4 specific) |
MF | IBA | GO:0044212 | transcription regulatory region DNA binding |
Gene expression in normal tissue: ASH2L
Gene-model tissue-cancer distribution: Bubble Plot
Gene-drug pathway distribution
Pathways in ASH2L
Loading, please wait...
Database | Pathway ID | Pathway Des. |
---|---|---|
wikipathways | WP2004 | miR-targeted genes in lymphocytes - TarBase |
wikipathways | WP2005 | miR-targeted genes in muscle cell - TarBase |
kegg | hsa04934 | Cushing,s syndrome - Homo sapiens (human) |
reactome | R-HSA-1266738 | Developmental Biology |
reactome | R-HSA-162582 | Signal Transduction |
reactome | R-HSA-195721 | Signaling by WNT |
Gene-Drug: Aster Plot
Gene in drug-gene network: Network Plot

Gene-drug targets distribution
Gene Structure: PDB
Models in ASH2L
Loading, please wait...
Model | Level | Reference ID | Tissue | Cancer | Drug | Clinical Response | Source | |
---|---|---|---|---|---|---|---|---|
No matching records found |